CN Patent

CN113045569B — 用作ret激酶抑制剂的化合物及其应用

Assigned to Deuracor Therapeutic Inc · Expires 2022-04-19 · 4y expired

What this patent protects

本发明涉及用作RET激酶抑制剂的化合物及其应用，其具有式F所示结构，所述化合物对RET激酶均有很好的抑制能力，且具有较好的药效学、药代动力学性能和更低的毒副作用。

USPTO Abstract

本发明涉及用作RET激酶抑制剂的化合物及其应用，其具有式F所示结构，所述化合物对RET激酶均有很好的抑制能力，且具有较好的药效学、药代动力学性能和更低的毒副作用。

Drugs covered by this patent

Patent Metadata

Patent number
CN113045569B
Jurisdiction
CN
Classification
—
Expires
2022-04-19
Drug substance claim
No
Drug product claim
No
Assignee
Deuracor Therapeutic Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.